Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Depressive symptoms in neurodegenerative diseases.

Baquero M, Martín N.

World J Clin Cases. 2015 Aug 16;3(8):682-93. doi: 10.12998/wjcc.v3.i8.682. Review.

2.

Memantine: New prospective in bipolar disorder treatment.

Serra G, Demontis F, Serra F, De Chiara L, Spoto A, Girardi P, Vidotto G, Serra G.

World J Psychiatry. 2014 Dec 22;4(4):80-90. doi: 10.5498/wjp.v4.i4.80. Review.

3.

Evaluation of the effect of Cyperus rotundus L. in scopolamine-induced learning deficit in mice.

Rabbani M, Ghannadi A, Malekian N.

Adv Biomed Res. 2014 Oct 21;3:217. doi: 10.4103/2277-9175.143293. eCollection 2014.

4.

The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.

Sasaki S, Horie Y.

Dement Geriatr Cogn Dis Extra. 2014 May 21;4(2):131-9. doi: 10.1159/000362871. eCollection 2014 May.

5.

Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).

Drye LT, Scherer RW, Lanctôt KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE; ADMET Research Group.

Am J Geriatr Psychiatry. 2013 Jun;21(6):549-59. doi: 10.1016/j.jagp.2012.12.018. Epub 2013 Jan 18.

6.

An update on the diagnosis and management of dementing conditions.

Maalouf M, Ringman JM, Shi J.

Rev Neurol Dis. 2011;8(3-4):e68-87. Review.

7.

Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial.

Stella F, Canonici AP, Gobbi S, Galduroz RF, Cação Jde C, Gobbi LT.

Clinics (Sao Paulo). 2011;66(8):1353-60.

8.

Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia.

Christofoletti G, Oliani MM, Bucken-Gobbi LT, Gobbi S, Beinotti F, Stella F.

Clinics (Sao Paulo). 2011;66(4):613-8.

9.

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.

Bachinskaya N, Hoerr R, Ihl R.

Neuropsychiatr Dis Treat. 2011;7:209-15. doi: 10.2147/NDT.S18741. Epub 2011 Apr 20.

10.

Memantine effects on liver and adrenal gland of rats exposed to cold stress.

Ferreira M, Valenti VE, Cisternas JR, Ferreira C, Meneghini A, Filho CF, Breda JR, Correa JA, de Mello Monteiro CB, Junior HM, Murad N, de Abreu LC.

Int Arch Med. 2011 Jan 22;4(1):5. doi: 10.1186/1755-7682-4-5.

11.

Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Lanctôt KL, Rajaram RD, Herrmann N.

Ther Adv Neurol Disord. 2009 May;2(3):163-80. doi: 10.1177/1756285609102724.

12.

A new strategy for antidepressant prescription.

Lavergne F, Jay TM.

Front Neurosci. 2010 Nov 19;4:192. doi: 10.3389/fnins.2010.00192. eCollection 2010.

13.

Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.

Fernández M, Gobartt AL, Balañá M; COOPERA Study Group.

BMC Neurol. 2010 Sep 28;10:87. doi: 10.1186/1471-2377-10-87.

14.

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer's disease.

Puangthong U, Hsiung GY.

Neuropsychiatr Dis Treat. 2009;5:553-61. Epub 2009 Nov 2.

Supplemental Content

Support Center